<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000045340"><TermName>iododoxorubicin</TermName><TermPronunciation>(I-oh-doh-DOK-soh-ROO-bih-sin)</TermPronunciation><TermDefinition><DefinitionText>A substance that is being studied as a treatment for cancer and for primary systemic amyloidosis (a disease in which proteins are deposited in specific organs). It is a type of anthracycline antitumor antibiotic.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000705343" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;iododoxorubicin&quot;" language="en" id="_3"/><MediaLink ref="CDR0000705342" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;iododoxorrubicina&quot;" language="es" id="_4"/><SpanishTermName>iododoxorrubicina</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia en estudio para el tratamiento del cáncer y la amiloidosis sistémica primaria (enfermedad en que las proteínas se depositan en órganos específicos). Es un tipo de antibiótico antitumoral de antraciclina.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateLastModified>2007-03-09</DateLastModified></GlossaryTerm>
